When cancer is described as “advanced,” that means it has started to spread.  Today, progress in understanding the origins of cancer and the development of new medications have improved patients' odds of living with and beyond advanced cancers.

In the second of our series on lung cancer, we continue our conversation with one of the nation's experts on the subject. D. Ross Camidge , MD, PhD , is a well-known lung cancer specialist and director of the thoracic oncology clinical program at the University of Colorado.